NHS Logo
  • Home
  • About Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter
  • Contact Us

Diagnostic Stories

DiagnosticInnovation New Hepatitis C cases down by almost 70 per cent in HIV positive men

DiagnosticInnovation New Hepatitis C cases down by almost 70 per cent in HIV positive men

Published on 31st March 2020
DiagnosticInnovation Alzheimer’s brain ‘atlas’ may help identify new treatments

DiagnosticInnovation Alzheimer’s brain ‘atlas’ may help identify new treatments

Published on 30th March 2020
DiagnosticInnovationPartnershipPreventionTherapeutic Focus on COVID-19 research at Imperial

DiagnosticInnovationPartnershipPreventionTherapeutic Focus on COVID-19 research at Imperial

Published on 26th March 2020
AwardDiagnosticPreventionTherapeutic Imperial researchers secure funds to help tackle COVID-19

AwardDiagnosticPreventionTherapeutic Imperial researchers secure funds to help tackle COVID-19

Published on 26th March 2020
DiagnosticPreventionTherapeutic COVID-19 Statement from the BRC Director

DiagnosticPreventionTherapeutic COVID-19 Statement from the BRC Director

Published on 24th March 2020
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Treatment Flexible hepatitis C treatments could pave the way for elimination
  • Training NIHR Imperial BRC pre-application support funds
  • Prevention Progesterone-only contraceptive pill linked to increased asthma risk in some women
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre